Terns Pharmaceuticals, Inc. (TERN)
35.48
-2.29
(-6.06%)
USD |
NASDAQ |
Jan 09, 16:00
35.10
-0.38
(-1.07%)
After-Hours: 20:00
Terns Pharmaceuticals Research and Development Expense (Quarterly): 19.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Altimmune, Inc. | 14.93M |
| Ligand Pharmaceuticals, Inc. | 21.02M |
| ADMA Biologics, Inc. | 1.528M |
| Viking Therapeutics, Inc. | 89.95M |
| Cidara Therapeutics, Inc. | 35.53M |